Skip to main content
. 2020 Oct 23;35(2):e23601. doi: 10.1002/jcla.23601

Figure 3.

Figure 3

Receiver operating characteristics (ROC) curve analysis of the logit model with fecal lncRNAs CCAT1, CCAT2, H19, HOTAIR, HULC, MALAT1, MEG3, PCAT1, PTENP1, and TUSC7, on the validation set. A, The area under the ROC curve (AUC) assessment of the logit(p) value for the fecal lncRNAs panel in distinguishing colorectal cancer (CRC) cases (All TNM stages) from the healthy controls. B, AUC assessment of the logit(p) value for the fecal lncRNAs panel in distinguishing the early CRC stages (I‐II TNM stages) from the healthy controls. C, AUC assessment of the logit(p) value for the fecal lncRNAs panel in distinguishing the advanced CRC stages (III‐IV TNM stages) from the healthy controls. logit(p) = 27.886 − 0.1969 × (CCAT1) − 0.1904 × (CCAT2) − 0.2986 × (H19) − 0.6895 × (HOTAIR) − 0.1194 × (HULC) − 0.3598 × (MALAT1) − 0.1278 × (MEG3) − 0.1744 × (PCAT1) − 0.9081 × (PTENP1) − 0.8469 × (TUSC7)